Supported by

Mitral valve replacement and repair

Latest mitral valve replacement and repair content in interventional cardiology - research, practice, and education

Building on the years of experience with TAVI, mitral valve replacement and repair (TMVR) is now beginning to take-off with a vast array of new techniques and options. Certain devices, for instance in mitral repair, are now widely used. To understand this complex field a knowledge and mastery is required covering the latest research, emerging tools, devices and techniques, vascular access; the role of adjunctive pharmacotherapy; imaging techniques such as echocardiography as well as understanding bleeding risks or patient selection. Find out more…

Filtered By
Mitral valve replacement and repair

634 results

Jon DeHaan Foundation and the Michele Pighi Young Investigator Awards 2026

21 May 2026

At EuroPCR 2026, two awards highlighted innovation and emerging talent in interventional cardiology. Lene Andreasen received the Michele Pighi Young Investigator Award for her research on coronary bifurcation PCI from the OCTOBER trial, while Susheel Kodali and the Nyra Medical team were honoured with the Jon...

Jon DeHaan Foundation Award and the Michele Pighi Young Investigator Award

Jon DeHaan Foundation Award 2026: presentation of the foundation, the winner and his project

21 May 2026 – From EuroPCR 2026

In this exclusive EuroPCR 2026 interview, Jose Calle Gordo, Tom DeHaan, and Susheel Kodali discuss the 2026 Jon DeHaan Foundation Award and the innovation behind this year’s winning project.

Discover how nearly 500 submissions were reviewed to identify the top innovations in interventional cardiology, and learn more...

Inside the Jon DeHaan Foundation Award 2026

Transcatheter mitral valve replacement - LIVE case

20 May 2026 – From EuroPCR 2026

A 65‑year‑old woman with obesity (BMI 38.7), prior cardiac surgery (CABG to OM and LAD in 2012), and chronic kidney disease presented with symptomatic severe mitral regurgitation (Carpentier type III: type IIIa due to calcification and type IIIb post‑MI) with moderately reduced LVEF (45%).

A transcatheter mitral...

Transcatheter mitral valve replacement - LIVE case

Advanced mitral TEER strategies in complex clinical scenarios

20 May 2026 – From EuroPCR 2026

This session presents advanced strategies for mitral transcatheter edge-to-edge repair (TEER) in complex clinical settings. Through cases involving surgical ring dehiscence, acute mitral regurgitation, dextrocardia, congenital anomalies, severe annular calcifications, and creative procedural approaches, it explores the expanding role of TEER. The session provides guidance on...

Structural heart devices: what's new and how it reaches your cathlab

20 May 2026 – From EuroPCR 2026

Discover the latest innovations in structural heart devices, spanning new TAVR platforms, mitral and tricuspid valve technologies, leaflet modification, and closure devices. Gain insight into the comprehensive innovation pathway from concept and prototyping to regulatory approval and clinical adoption, with perspectives from physician-innovators on drivers of...

Other valvular and structural interventions

20 May 2026 – From EuroPCR 2026

Covering a spectrum of valvular and structural heart interventions, this session discusses systemic aortic valve TEER in complex congenital cases, compares TAVI and surgical AVR outcomes via meta-analysis, highlights radiation protection advances in complex endovascular repair, and presents combined mitral and tricuspid TEER techniques, novel ultrasound...

Other valvular and structural interventions

Registries and trials in TMVR

20 May 2026 – From EuroPCR 2026

This session provides an in-depth review of registries and clinical trials focused on transcatheter mitral valve replacement (TMVR). It presents data on annular and ventricular remodeling with the HighLife system, mid- to long-term valve performance, and innovations in transseptal TMVR using novel bioprostheses.

Mitral valve-in-valve, valve-in-ring, valve replacement: procedure challenges

20 May 2026 – From EuroPCR 2026

This session addresses procedural challenges in mitral valve interventions, including valve-in-valve, valve-in-ring, and valve replacement techniques. It covers lifetime management of patients with atrial fixated transcatheter mitral valve replacement (TMVR), approaches to recurrent mitral regurgitation, complex valve-in-valve cases, and hybrid strategies for valve-in-ring implantation, highlighting innovative...

AI adoption in the cathlab of tomorrow - Risk prediction applications

20 May 2026 – From EuroPCR 2026

This session delves into the adoption of artificial intelligence in the cath lab, focusing on clinically useful risk prediction models for coronary and structural interventions. It covers advanced AI-guided intravascular imaging, machine learning applications for adverse event prediction, and critical evaluation of model validation and clinical...

Mitral valve-in-valve, valve-in-ring, valve-in-mac: the good, the bad and the ugly

20 May 2026 – From EuroPCR 2026

This session delves into the complexities of mitral valve interventions, focusing on valve-in-valve, valve-in-ring, and valve-in-mitral annular calcification (MAC) procedures. It addresses troubleshooting in high-risk valve-in-MAC cases, urgent transcatheter mitral valve implantation supported by microaxial flow pumps, challenges in delivering balloon expandable valves transeptally, and innovative...